152 related articles for article (PubMed ID: 34190429)
21. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
22. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
[TBL] [Abstract][Full Text] [Related]
23. Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study.
Tao H; O'Neil A; Choi Y; Wang W; Wang J; Wang Y; Jia Y; Chen X
Front Endocrinol (Lausanne); 2020; 11():60. PubMed ID: 32132977
[No Abstract] [Full Text] [Related]
24. Prediagnosis Sleep Duration, Napping, and Mortality Among Colorectal Cancer Survivors in a Large US Cohort.
Xiao Q; Arem H; Pfeiffer R; Matthews C
Sleep; 2017 Apr; 40(4):. PubMed ID: 28329353
[TBL] [Abstract][Full Text] [Related]
25. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening.
Abdelsattar ZM; Wong SL; Regenbogen SE; Jomaa DM; Hardiman KM; Hendren S
Cancer; 2016 Mar; 122(6):929-34. PubMed ID: 26808454
[TBL] [Abstract][Full Text] [Related]
26. Time from incident primary cancer until recurrence or second primary cancer: Risk factors and impact in general practice.
Rasmussen LA; Jensen H; Virgilsen LF; Falborg AZ; Møller H; Vedsted P
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13123. PubMed ID: 31231898
[TBL] [Abstract][Full Text] [Related]
27. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas.
Lin SS; Clarke CA; Prehn AW; Glaser SL; West DW; O'Malley CD
Cancer; 2002 Feb; 94(4):1175-82. PubMed ID: 11920489
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological Features and Survival Outcomes of Colorectal Cancer in Young Versus Elderly: A Population-Based Cohort Study of SEER 9 Registries Data (1988-2011).
Wang R; Wang MJ; Ping J
Medicine (Baltimore); 2015 Sep; 94(35):e1402. PubMed ID: 26334895
[TBL] [Abstract][Full Text] [Related]
29. The impact of pre-existing cancer on survival of prostate cancer patients: A population-based study.
Zhou Y; Guan H; Fu Y; Mao L; Ge J; Liu L; Cheng L; Guan C
Medicine (Baltimore); 2018 Dec; 97(50):e13479. PubMed ID: 30558003
[TBL] [Abstract][Full Text] [Related]
30. Temporal trend in relative risk of second primary colorectal cancer.
Das A; Chak A; Cooper GS
Am J Gastroenterol; 2006 Jun; 101(6):1342-7. PubMed ID: 16771959
[TBL] [Abstract][Full Text] [Related]
31. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.
Howlader N; Mariotto AB; Woloshin S; Schwartz LM
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):255-64. PubMed ID: 25417239
[TBL] [Abstract][Full Text] [Related]
32. Secular trends in colon and rectal cancer relative survival.
Rutter CM; Johnson EA; Feuer EJ; Knudsen AB; Kuntz KM; Schrag D
J Natl Cancer Inst; 2013 Dec; 105(23):1806-13. PubMed ID: 24174654
[TBL] [Abstract][Full Text] [Related]
33. Impact of prior cancer history on survival of patients with gastric cancer.
Wen L; Yu K; Lu H; Zhong G
Eur J Surg Oncol; 2021 Sep; 47(9):2286-2294. PubMed ID: 33632589
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database.
Cheng E; Blackburn HN; Ng K; Spiegelman D; Irwin ML; Ma X; Gross CP; Tabung FK; Giovannucci EL; Kunz PL; Llor X; Billingsley K; Meyerhardt JA; Ahuja N; Fuchs CS
JAMA Netw Open; 2021 Jun; 4(6):e2112539. PubMed ID: 34132794
[TBL] [Abstract][Full Text] [Related]
35. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.
Hassett MJ; Ritzwoller DP; Taback N; Carroll N; Cronin AM; Ting GV; Schrag D; Warren JL; Hornbrook MC; Weeks JC
Med Care; 2014 Oct; 52(10):e65-73. PubMed ID: 23222531
[TBL] [Abstract][Full Text] [Related]
36. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
37. Trends in Sociodemographic Disparities in Colorectal Cancer Staging and Survival: A SEER-Medicare Analysis.
Liang PS; Mayer JD; Wakefield J; Trinh-Shevrin C; Kwon SC; Sherman SE; Ko CW
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00155. PubMed ID: 32352722
[TBL] [Abstract][Full Text] [Related]
38. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis.
Balkrishnan R; Desai RP; Narayan A; Camacho FT; Flausino LE; Chammas R
Cancer Med; 2021 Aug; 10(15):5347-5357. PubMed ID: 34184420
[TBL] [Abstract][Full Text] [Related]
39. Second primary malignancies in colorectal cancer patients.
Halamkova J; Kazda T; Pehalova L; Gonec R; Kozakova S; Bohovicova L; Krakorova DA; Slaby O; Demlova R; Svoboda M; Kiss I
Sci Rep; 2021 Feb; 11(1):2759. PubMed ID: 33531585
[TBL] [Abstract][Full Text] [Related]
40. Mortality rates by stage-at-diagnosis.
Clinton K
Semin Surg Oncol; 1994; 10(1):7-11. PubMed ID: 8115787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]